CAPELIEVA-DT 500 MG (Capecitabine Dispersible Tablets 500 mg) is an oral chemotherapy medicine used in the treatment of various cancers, including colorectal cancer, breast cancer, and gastric cancer. It contains Capecitabine 500 mg, a fluoropyrimidine antineoplastic agent that is converted into its active form, 5-Fluorouracil (5-FU), within the body. This targeted conversion allows the medicine to interfere with cancer cell growth and multiplication while supporting effective cancer management.

Cancer cells grow and divide much faster than normal cells. Capecitabine works by disrupting DNA synthesis in rapidly dividing cells, preventing tumor growth and slowing the progression of cancer. Because the active medicine is produced in higher concentrations within tumor tissues, Capecitabine has become an important component of modern cancer treatment protocols.

CAPELIEVA-DT 500 MG is formulated as a dispersible tablet, offering greater convenience for patients who may have difficulty swallowing conventional tablets. The tablet can be dispersed according to the instructions provided by healthcare professionals, ensuring easier administration and better treatment compliance.

This medicine is widely prescribed by oncologists for patients diagnosed with:

     • Colorectal Cancer

     • Colon Cancer

     • Rectal Cancer

     • Metastatic Colorectal Cancer

     • Breast Cancer

     • Metastatic Breast Cancer

     • Gastric (Stomach) Cancer

     • Gastroesophageal Cancer

     • Advanced Solid Tumors

     • Combination Chemotherapy Programs

Capecitabine may be used alone or alongside other anticancer medicines depending on the patient's condition, cancer stage, and treatment goals. It is frequently included in personalized cancer treatment plans designed to improve outcomes and support long-term disease control.

Manufactured under stringent pharmaceutical quality standards, CAPELIEVA-DT 500 MG provides reliable therapeutic performance, safety, and consistency. The medicine should only be used under the supervision of qualified oncologists or healthcare professionals experienced in cancer care.

Patients receiving Capecitabine therapy often require regular blood tests, liver function monitoring, kidney assessments, and medical evaluations to ensure safe and effective treatment. These routine assessments help healthcare providers monitor treatment response and identify any potential side effects early.

Due to its proven effectiveness and convenience as an oral chemotherapy option, CAPELIEVA-DT 500 MG remains an important part of modern oncology treatment programs worldwide.

CAPELIEVA-DT 500 MG (Capecitabine Dispersible Tablets 500 mg) is primarily used for the treatment and management of several types of cancer.

Common Uses of CAPELIEVA-DT 500 MG

1. Colorectal Cancer

The medicine is widely used for the treatment of colon and rectal cancers, helping slow tumor growth and disease progression.

2. Metastatic Colorectal Cancer

Doctors may prescribe Capecitabine when colorectal cancer has spread to other parts of the body.

3. Breast Cancer

CAPELIEVA-DT is frequently used in the treatment of advanced and metastatic breast cancer.

4. Gastric Cancer

The medicine may be included in treatment protocols for stomach cancer and gastroesophageal cancers.

5. Combination Chemotherapy Treatment

Capecitabine is often used with other anticancer medicines to improve treatment outcomes.

6. Long-Term Oncology Care

The medicine supports comprehensive cancer management and long-term disease control.

---

How CAPELIEVA-DT 500 MG Works

Capecitabine belongs to a class of medicines known as antimetabolite chemotherapy agents.

CAPELIEVA-DT works by:

     • Converting into active 5-Fluorouracil (5-FU)

     • Blocking cancer cell DNA synthesis

     • Preventing tumor cell multiplication

     • Slowing cancer progression

     • Supporting targeted chemotherapy treatment

     • Helping reduce tumor growth

This mechanism helps control rapidly dividing cancer cells while supporting modern oncology treatment strategies.

Like all chemotherapy medicines, CAPELIEVA-DT 500 MG may cause side effects in some patients. The severity of side effects varies depending on individual response and treatment duration.

Common Side Effects

1. Diarrhea

Loose stools and digestive disturbances are among the most common side effects.

2. Nausea

Patients may experience mild to moderate nausea during therapy.

3. Vomiting

Some individuals may develop episodes of vomiting.

4. Fatigue

Weakness, tiredness, and low energy levels may occur.

5. Loss of Appetite

Reduced appetite may affect food intake during treatment.

6. Hand-Foot Syndrome

Redness, swelling, pain, or peeling of the palms and soles may occur.

7. Mouth Ulcers

Oral sores and irritation may develop during treatment.

8. Abdominal Pain

Some patients may experience stomach discomfort or abdominal pain.

9. Weight Loss

Weight loss may occur as a result of treatment-related side effects.

---

Serious Side Effects

Seek immediate medical attention if you experience:

     • Severe diarrhea

     • Persistent vomiting

     • High fever

     • Severe dehydration

     • Chest pain

     • Difficulty breathing

     • Unusual bleeding or bruising

      • Severe allergic reactions

      • Signs of serious infection

Patients should contact their healthcare provider immediately if serious symptoms occur.

The dosage of CAPELIEVA-DT 500 MG (Capecitabine Dispersible Tablets 500 mg) should always be determined by a qualified healthcare professional.

Factors Affecting Dosage

1. Type of Cancer

Treatment dosage depends on the specific cancer diagnosis.

2. Body Surface Area (BSA)

Capecitabine dosage is often calculated according to the patient's body size.

3. Kidney Function

Patients with impaired kidney function may require dosage adjustments.

4. Treatment Response

Doctors may modify therapy based on effectiveness and side effect management.

5. Combination Therapy

Dosage requirements may differ when used with other chemotherapy medicines.

---

Important Dosage Instructions

     • Take the medicine exactly as prescribed.

     • Use the dispersible tablet according to medical instructions.

     • Follow the treatment schedule carefully.

     • Do not alter the prescribed dose.

     • Attend all follow-up appointments.

     • Continue therapy only under medical supervision.

Regular laboratory monitoring is essential during treatment.

---

Precautions Before Using CAPELIEVA-DT 500 MG

Before starting treatment, patients should inform their doctor if they have:

     • Kidney disease

     • Liver disease

     • Heart disease

     • Blood disorders

     • Previous chemotherapy complications

     • Known allergies to fluoropyrimidine medicines

Patients should also disclose all prescription medicines, supplements, and herbal products they are currently using to avoid potential drug interactions.

Pregnant or breastfeeding women should use this medicine only if specifically advised by a healthcare professional.

---

Storage Instructions

     • Store in a cool and dry place.

     • Protect from direct sunlight and moisture.

     • Keep out of reach of children.

     • Store at recommended room temperature.

---

Why Choose CAPELIEVA-DT 500 MG?

     • Trusted Capecitabine formulation

     • Convenient dispersible tablet dosage form

     • Effective oral chemotherapy option

     • Supports colorectal, breast, and gastric cancer treatment

     • Manufactured under strict pharmaceutical quality standards

     • Suitable for modern oncology treatment protocols

     • Reliable long-term cancer management support

---

Frequently Asked Questions (FAQs)

What is CAPELIEVA-DT 500 MG used for?

It is used for the treatment of colorectal cancer, breast cancer, gastric cancer, and related oncology conditions.

What is Capecitabine?

Capecitabine is an oral chemotherapy medicine that converts into 5-Fluorouracil (5-FU) within the body to help destroy cancer cells.

Is CAPELIEVA-DT a chemotherapy medicine?

Yes, Capecitabine is an antimetabolite chemotherapy medicine used in various cancer treatment programs.

What are dispersible tablets?

Dispersible tablets are designed to be dispersed according to healthcare provider instructions, making administration easier for certain patients.

Can CAPELIEVA-DT cause hand-foot syndrome?

Yes, redness, pain, swelling, or peeling of the hands and feet can occur during treatment.

Is regular monitoring necessary during therapy?

Yes, doctors typically recommend blood tests, liver function monitoring, kidney assessments, and routine medical evaluations.

Can patients stop treatment without consulting a doctor?

No, treatment should only be modified or discontinued under medical supervision.

Should CAPELIEVA-DT be used under medical supervision?

Yes, this medicine should always be used under the guidance of qualified healthcare professionals experienced in oncology and cancer care.